机构:[1]Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China[2]Department of Neurobiology and Acupuncture Research, The Third Clinical Medical College, Zhejiang Chinese Medical University, Key Laboratory of Acupuncture and Neurology of Zhejiang Province, Hangzhou, Zhejiang, P.R. China[3]Department of Immune-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China河北医科大学第四医院[4]Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China临床科室河北省肿瘤研究所河北医科大学第四医院
Growing evidence has demonstrated that transforming acidic coiled-coil protein 3 (TACC3), a member of the TACC family, may be involved in regulating cell mitosis, transcription, and tumorigenesis. However, the role of TACC3 in kidney renal clear cell carcinoma (KIRC) remains unknown. In this study, multiple databases were used to determine the pattern of TACC3 in KIRC. We found that high TACC3 expression was associated with poor overall survival (OS) in stage I, II, IV and grade 3 KIRC patients. Univariate and multivariate Cox regression analyses showed that TACC3 was an independent risk factor for OS among KIRC patients. Moreover, TACC3 expression correlated with immune cell infiltration levels of B cells, T cells (CD8+, CD4+, follicular helper, regulatory and gamma delta), total and resting natural killer cells, total and activated dendritic cells, and resting mast cells. Furthermore, T cell exhaustion markers, such as PD1, CTLA4, LAG3 and TIM-3 were highly expressed in TACC3 overexpressing tissues. In addition, GSEA analysis revealed that the role of TACC3 in KIRC may be closely linked to immune-associated pathways. Therefore, our study reveals that TACC3 is a prognostic biomarker for OS among KIRC patients and may be associated with immune cell infiltration and T cell exhaustion.
基金:
Natural Science Foundation of Hebei Province (H20206360), Administration of Traditional Chinese Medicine of Hebei Province (2018139), projects from Health and Family Planning Commission of Hebei Province (Grant No.20190738 and 20190007) and research funding from Zhejiang Chinese Medical University (Q2019J01).
第一作者机构:[1]Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, P.R. China
共同第一作者:
通讯作者:
通讯机构:[3]Department of Immune-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China[4]Laboratory of Pathology, Hebei Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, P.R. China
推荐引用方式(GB/T 7714):
Fan Xiaoyan,Liu Boyi,Wang Zhiyu,et al.TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.[J].AGING-US.2021,13(6):8541-8562.doi:10.18632/aging.202668.
APA:
Fan Xiaoyan,Liu Boyi,Wang Zhiyu&He Dongwei.(2021).TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion..AGING-US,13,(6)
MLA:
Fan Xiaoyan,et al."TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion.".AGING-US 13..6(2021):8541-8562